U.S. Bioprocess Bags Market Size & Outlook, 2024-2030
U.S. bioprocess bags market, 2018-2030 (US$M)
Related Markets
U.S. bioprocess bags market highlights
- The U.S. bioprocess bags market generated a revenue of USD 1,300.6 million in 2024 and is expected to reach USD 2,964.9 million by 2030.
- The U.S. market is expected to grow at a CAGR of 14.7% from 2025 to 2030.
- In terms of segment, upstream process was the largest revenue generating workflow in 2024.
- Downstream Process is the most lucrative workflow segment registering the fastest growth during the forecast period.
Bioprocess bags market data book summary
| Market revenue in 2024 | USD 1,300.6 million |
| Market revenue in 2030 | USD 2,964.9 million |
| Growth rate | 14.7% (CAGR from 2024 to 2030) |
| Largest segment | Upstream process |
| Fastest growing segment | Downstream Process |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Upstream Process, Downstream Process, Process Development |
| Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius AG, Danaher Corp, Merck KGaA, Compagnie de Saint-Gobain SA, Corning Inc, Entegris Inc, Meissner, ProAnalytics, CellBios |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.3% of the global bioprocess bags market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. bioprocess bags market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 283.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bioprocess Bags Market Scope
Bioprocess Bags Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. bioprocess bags market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioprocess bags market will help companies and investors design strategic landscapes.
Upstream process was the largest segment with a revenue share of 43.5% in 2024. Horizon Databook has segmented the U.S. bioprocess bags market based on upstream process, downstream process, process development covering the revenue growth of each sub-segment from 2018 to 2030.
The substantial share of the U.S. in the regional market can be attributed mainly to the presence of large-scale manufacturing facilities for biopharmaceuticals. The biopharmaceutical sector is considered the most R&D-intensive in the U.S., and its development is recognized as a high-impact factor in the industry.
Consequently, this can drive the adoption of bioprocess bags in the coming years for a flexible and fast approach, thus leading to significant revenue generation in the U.S. Furthermore, the U.S. FDA has estimated that it will be approving around 10 to 20 cell & gene therapy products each year by 2025 due to the current clinical success rates and promising product pipeline.
This can result in the rapid adoption of disposable bags and other single-use equipment in the biopharmaceutical industry, which can help curb the demand-supply gap in the coming years. Moreover, many companies are involved in developing their manufacturing capabilities to support the increasing demand.
Reasons to subscribe to U.S. bioprocess bags market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. bioprocess bags market databook
-
Our clientele includes a mix of bioprocess bags market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. bioprocess bags market , including forecasts for subscribers. This country databook contains high-level insights into U.S. bioprocess bags market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. bioprocess bags market size, by workflow, 2018-2030 (US$M)
U.S. Bioprocess Bags Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
